During my OBGYN site visit, I had the opportunity to discuss several interesting gynecologic cases and review a journal article on Vaginal Microbiota Transplantation (VMT) for recurrent bacterial vaginosis. The article explored how restoring a healthy Lactobacillus-dominant vaginal microbiome may offer a future treatment option for recurrent BV and potentially other gynecologic conditions. I found it interesting because it focused on treating the underlying microbiome imbalance rather than repeatedly treating patients with antibiotics alone.

We also reviewed multiple patient cases that helped strengthen my clinical reasoning skills. One patient presented with recurrent tubo-ovarian abscess (TOA) requiring admission for IV ceftriaxone, doxycycline, and metronidazole. Through this case, I learned more about the progression of pelvic inflammatory disease and how TOA develops as a complication of ascending infection. We discussed the rationale for broad-spectrum antibiotic coverage, indications for surgical consultation, and when interventional radiology drainage should be considered in patients who fail conservative management. Another patient presented with chronic lower abdominal pain, vaginal itching, and abnormal spotting while requesting evaluation of her Paragard IUD. This case reinforced the importance of developing a broad differential diagnosis including pelvic inflammatory disease, cervicitis, vaginitis, urinary tract infection, and IUD-related complications. It also highlighted the significance of performing a thorough pelvic examination and obtaining appropriate testing to identify the underlying cause of symptoms. One of the most valuable aspects of this rotation was how my professor consistently emphasized understanding the pathophysiology behind disease processes and treatment decisions rather than simply memorizing management plans. We frequently discussed why specific laboratory studies were ordered, such as trending CBC values to monitor for leukocytosis and response to treatment in infectious processes. We reviewed the purpose of imaging studies and how findings guide clinical decision making.

My professor also spent time reviewing pharmacology in a practical clinical context. Rather than only knowing which medication to prescribe, we discussed why a medication was chosen, the appropriate dosage, route of administration, and expected effects. For example, we reviewed medications such as misoprostol and discussed how route of administration can affect absorption and clinical outcomes. These discussions helped me better understand the rationale behind treatment decisions and improved my ability to connect pharmacology with patient care. Overall, this site visit strengthened my understanding of gynecologic pathology, diagnostic evaluation, and evidence-based management while reinforcing the importance of understanding the reasoning behind every test, medication, and intervention ordered for a patient.